New Chair for Australian Sports Foundation

Minister for Sport Richard Colbeck said the appointment of businessman and administrator Grant O’Brien marked a new chapter for the organisation as it continues its vital role raising private funds for the development of sport across the country.
Mr O’Brien has been a member of the ASF Board since October 2020.
He has extensive experience in business management and leadership, including as chief executive and managing director of Woolworths Ltd.
He is also deputy chairman of the Stars Foundation, which aims to empower Indigenous girls and young women, and a founding member and director of Avner Pancreatic Cancer Foundation.
He will served in the role for a three year term.
Mr O’Brien said he was looking forward to the challenges ahead.
“Sport is an important part of our Australian culture, and I have experienced first-hand the powerful benefits of participation,” Mr O’Brien said.
“I’m excited about the opportunity to extend the impact of the Australian Sports Foundation and help raise more funds to increase participation and improve the health and cohesion of our communities.”
Minister Colbeck said Mr O’Brien stepped into the role as the sports sector continues its recovery from the impact of the global pandemic.
“Mr O’Brien has the experience and expertise needed to stimulate philanthropic funding and allow Australia’s sporting sector to recover and thrive,” Minister Colbeck said.
For more than 30 years, it has helped to raise more than $520 million to support athletes, clubs and sporting organisations.
It has funded all sports at all levels and is the only sport fundraising organisation to which donations are tax deductible.
Minister Colbeck also extended his thanks to the outgoing ASF Chairperson, Mark Stockwell.
“During his seven years as chairperson, Mr Stockwell has done a tremendous amount for Australian sport,” he said.
“Under his leadership, the ASF has raised record amounts of funding, rising to an annual total of more than $50 million before the pandemic hit.”

Support for mandatory vaccination of residential aged care workers

The Morrison Government is helping aged care workers get vaccinated as part of an $11 million grant program.
Applications are now open for aged care providers to apply for the funding following recommendations mandatory vaccinations be introduced.
The program was established in recognition of the individual circumstances of aged care workers now subject to the new requirement.
National Cabinet endorsed the decision of the Australian Health Protection Principal Committee to make COVID-19 vaccination mandatory for all residential aged care workers by mid-September 2021, when they are required to have at least a first dose of a COVID-19 vaccine.
The Residential Aged Care COVID-19 Employee Vaccination Support Grant will allow casual residential aged care workers to be paid under the following two categories via their employer:

  • A fee of $80 per staff member, per dose, for going off-site for vaccination; and
  • Paid sick leave if unwell after vaccination and the staff member has no other leave entitlements – a day’s paid leave (at a rate of $185).

Minister for Health and Aged Care, Greg Hunt, said the grants program is an important measure to help lift COVID-19 vaccination rates.
“It will help residential aged care workers who may need to travel to get vaccinated at the nearest hub, clinic or GP,” Minister Hunt said.
“The grants program will also help those workers who do not have leave entitlements to recover from any minor side effects and who may be concerned about losing wages after being vaccinated.”
Minister for Senior Australians and Aged Care Services, Richard Colbeck, said the grants program will also provide financial support for flexible vaccination facilitation costs.
Up to $500 per residential aged care facility will also be available under the grants program to contribute to costs that may be incurred in facilitating access to vaccination for workers.
“This will cover transport services, arranging groups of workers to be vaccinated and/or any other reasonable expenses that support workers to get vaccinated,” Minister Colbeck said.
“The Commonwealth will continue to work closely with the aged care sector, including the unions, to ensure support and access to COVID-19 vaccination for all workers in residential aged care.”
Minister Colbeck said ensuring all aged care workers are vaccinated will further protect the residents in their care.
“This is why COVID-19 vaccinations will be mandated for residential aged care workers as a condition of working in an aged care facility through shared state, territory and Commonwealth authorities and compliance measures,” he said.
The Morrison Government contracted vaccine workforce providers to deliver vaccination in-reach clinics to 2566 Commonwealth-subsidised residential aged care facilities for residents and, where additional vaccines were available, workers.
Providers are also now able to vaccinate their own workers on-site.  The request for tender is open until 30 July and so far more than 25,000 staff will be vaccinated through this program. All on-site vaccination programs will include Pfizer
Aged care providers can also consult with their Primary Health Network and GPs to organise on-site vaccination clinics for workers.
Workers accessing a COVID-19 vaccination through off-site clinics will also be offered Pfizer once it is available – this includes through general practices, Commonwealth vaccination clinics and state clinics.
From July 2021, around 1300 GPs will be administering Pfizer vaccinations, providing additional sites for vaccination.
Applications for the Residential Aged Care COVID-19 Employee Vaccination Support Grant can be found on the Australian Government’s GrantConnect website.

COVID-19 indemnity scheme to protect health professionals and patients

The Morrison Government is establishing a COVID-19 Vaccine Claim Scheme to provide further assurance and confidence to patients and health professionals in the COVID-19 vaccine rollout.
The creation of a fit-for-purpose COVID-19 vaccine medical indemnity scheme will support increased vaccination uptake by assuring Australians that health professionals, including GPs, nurses and pharmacists administering COVID vaccines as part of the Commonwealth vaccination program have appropriate indemnity coverage.
In the event someone suffers a significant adverse reaction, causing injury and economic loss because of vaccination, the Scheme will help guide potential claimants through a no fault claims process scheme.
Proven claims will be able to receive appropriate compensation without the need of formal court processes. Potential claimants accessing the scheme will still have the option of pursuing action through a court judgement if that is their preference.
The COVID-19 Vaccine Claims Scheme will be backdated to the start of the national vaccine rollout – 22 February 2021 – and will be linked to the Human Biosecurity Emergency Period under the Biosecurity Act 2015.
The scheme will support claims made against privately practising health professionals who administer a COVID-19 vaccine approved for use by the Therapeutic Goods Administration (TGA).
This scheme responds to calls from peak bodies including the Australian Medical Association and the Royal Australian College of General Practitioners, and medical indemnity insurers, for extended medical indemnity coverage for health professionals and their patients given the unique nature of the pandemic and response.
Details of the COVID-19 Vaccine Claims Scheme will be finalised in consultation with peak bodies, indemnity insurers, patient groups and states and territories.
To further support the choice of people considering their vaccine options, from 29 June the Government is extending two Medicare items that allow GPs and other medical practitioners to provide in-depth clinical assessments of a patient’s individual health risks and benefits. Already available for patients aged 50 years and over, these Medicare items will be available for all patients, regardless of age.

National Cabinet Statement

The National Cabinet met today for the 45th time to discuss Australia’s COVID-19 response, recent outbreaks of COVID-19 and the Australian COVID-19 Vaccine Strategy.
Since the beginning of the pandemic there have been 30,685 confirmed cases in Australia and, sadly, 910 people have died. Currently there are 4 cases in Australia requiring ICU hospitalisation and no cases on ventilators. More than 21 million tests have been undertaken in Australia.
Globally there have been over 182 million cases and sadly over 3.9 million deaths, with 429,948 new cases and 8,360 deaths reported in the last 24 hours. The COVID-19 pandemic continues to surge in many countries around the world.
Australia’s COVID-19 vaccine rollout continues to expand. As of yesterday, 7,970,153 doses of COVID-19 vaccines had been administered in Australia, including 163,178 doses in the previous 24 hours. Today Australia will reach its 8 millionth COVID-19 vaccination. In the previous 7 days, 807,777 vaccines have been administered in Australia.
To date, 30 per cent of the Australian adult population have now had a first dose of a COVID-19 vaccine, including over 50 per cent of over 50 year olds and over 70 per cent of over 70 year olds.
Chief Medical Officer Professor Paul Kelly provided an update on current outbreaks of COVID-19 in a number of locations and of both the Alpha and Delta variants.
Lieutenant General John Frewen, Coordinator General of Operation COVID Shield, provided a detailed briefing on the vaccination program.
National Cabinet agreed to meet next on 9 July 2021.
National Plan to transition Australia’s National COVID Response
National Cabinet agreed to formulate a National Plan to transition Australia’s National COVID Response from its current pre vaccination settings, focussing on continued suppression of community transmission, to post vaccination settings focussed on prevention of serious illness, hospitalisation and fatality, and the public health management of other infectious diseases.
National Cabinet agreed in-principle that the plan consists of the following phases, each triggered by the achievement of vaccination thresholds expressed as a percentage of the eligible population (16+), based on the scientific modelling currently being conducted for the COVID-19 Risk Analysis and Response Task Force.
The document is attached.
A. Current Phase – Vaccinate, prepare and pilot
Continue to suppress the virus for the purpose of minimising community transmission. Measures include:

  • Implement the national vaccination plan to offer every Australian an opportunity to be vaccinated with the necessary doses of the relevant vaccine as soon as possible;
  • Temporarily reduce commercial inbound passenger arrivals to all major ports by 50 per cent from current caps by 14 July to reduce the pressure on quarantine facilities, due to the increased risks of the Delta strain of the virus;
  • Lockdowns to be used only as a last resort;
  • Commonwealth to facilitate increased commercial flights to increase international repatriations to Darwin for quarantine at the National Resilience Facility at Howard Springs;
  • Commonwealth to extend additional support through the International Freight Assistance Mechanism to ensure maintenance of essential freight supply lines impacted by the reduction of commercial caps at international airports;
  • Trial and pilot the introduction of alternative quarantine options, including home quarantine for returning vaccinated travellers;
  • Expand commercial trials for limited entry of student and economic visa holders;
  • Recognise and adopt the existing digital Medicare Vaccination Certificate (automatically generated for every vaccination registered on AIR);
  • Establish digital vaccination authentication at international borders;
  • Prepare the vaccine booster programme; and
  • Undertake a further review of the national hotel quarantine network.

B. Post Vaccination Phase
Seek to minimise serious illness, hospitalisation and fatality as a result of COVID-19. Measures may include:

  • Ease restrictions on vaccinated residents – such as lockdowns and border controls;
  • Lockdowns only in extreme circumstances to prevent escalating hospitalisation and fatality;
  • Restore inbound passengers caps at previous levels for unvaccinated returning travellers and larger caps for vaccinated returning travellers;
  • Allow capped entry of student and economic visa holders subject to quarantine arrangements and availability;
  • Introduce new reduced quarantine arrangements for vaccinated residents; and
  • Prepare/implement the vaccine booster programme (depending on timing).

C. Consolidation Phase
Manage COVID-19 consistent with public health management of other infectious diseases. Measures may include:

  • No lockdowns;
  • Continue vaccine booster programme;
  • Exempt vaccinated residents from all domestic restrictions;
  • Abolish caps on returning vaccinated travellers;
  • Allow increased capped entry of student, economic, and humanitarian visa holders;
  • Lift all restrictions on outbound travel for vaccinated persons; and
  • Extend travel bubble for unrestricted travel to new candidate countries (Singapore, Pacific).

D. Final Phase
Manage COVID-19 consistent with public health management of other infectious diseases. Measures may include:

  • Allow uncapped inbound arrivals for all vaccinated persons, without quarantine; and
  • Allow uncapped arrivals of non-vaccinated travellers subject to pre-flight and on arrival testing.

National Cabinet agreed that the COVID-19 Risk Analysis and Response Task Force be tasked to make recommendations on finalising the plan, including recommended vaccination targets for each phase of the plan based on the modelling.
Phases will continue to maintain simple risk mitigation and prevention measures such as hygiene, tracing and testing.
National Partnership Agreement
National Cabinet welcomed the Commonwealth Government’s $752 million extension to the National Partnership on COVID-19 Response through to 30 June 2022. The National Partnership on COVID-19 Response provides Commonwealth funding to support state and territory efforts to address the pandemic, including the Hospital Services Payment, State Public Health Payment, Vaccine Schedule, Aged Care Schedule, and the Private Hospital Viability Guarantee.
Under the National Partnership on COVID-19 Response, the Commonwealth Government has provided to date an estimated $5.765 billion to support states and territories to proactively manage the COVID-19 pandemic as part of the broader Commonwealth health response which totals more than $27 billion.
International Passenger Arrivals
National Cabinet noted that international aviation remains critical to supporting the return of Australians from overseas as well as maintaining freight access (imports and exports) and Australia’s long-term international connectivity. It was also noted that international passenger arrival caps introduced by National Cabinet have been essential to safely managing and aligning international passenger arrivals with available quarantine capacity.
The Commissioner of Australian Border Force Michael Outram APM presented information to National Cabinet on international passenger arrivals which was noted. Around 83.9 per cent of travellers to Australia during June 2021 are Australian permanent residents and their families.
National Cabinet agreed to temporarily reduce the current international passenger arrival caps by 50 per cent to manage the pressure on quarantine facilities due to the increased risks posed by the Delta strain of the virus. These arrangements will:

  • commence by 12.01am Wednesday 14 July and remain in place until 31 August; and
  • be subject to a review by National Cabinet before the end of August and on a regular basis throughout the remainder of 2021.

National Cabinet agreed that returning Australians will continue to be prioritised as part of these arrangements.
Given the impact of the reduction in current cap arrangements the Commonwealth will fund an:

  • increased number of facilitated commercial (repatriation) flights, utilising capacity at the Centre for National Resilience at Howard Springs; and
  • extension of additional support through the International Freight Assistance Mechanism to maintain essential freight supply lines.

Significant step forward in aged care reform

The allocation of 80,000 new home care packages worth $6.5 billion and a basic daily fee increase for residential providers are the centrepiece of a raft of aged care reforms which start today.
In a continued response to the final report of the Royal Commission into Aged Care Quality and Safety, the latest measures from the Morrison Government put the health and wellbeing of senior Australians first.
Minister for Health and Aged Care Greg Hunt and Minister for Senior Australians and Aged Care Services, Richard Colbeck said it was another step in the Government’s implementation of generational reform.
From today, aged care providers must review the quality of their daily living services – with a particular focus on food and nutrition – to receive a new $10 per resident per day Government Basic Daily Fee supplement.
Residential aged care providers will be required to report on a quarterly basis from 2021-22, with the first report due in October 2021.
“This significant funding boost, worth $3.2 billion over five years, will provide a broad funding uplift to support the sector to deliver better care and services for residents,” Minister Hunt said.
“The new reporting requirements will strengthen provider accountability.
“A key focus of the reporting requirements will be to ensure providers are delivering high quality services to meet the living needs of residents, with a focus on food and nutrition.”
The new supplement will be paid monthly, with the first payment to be made in early August based on residents in care in July.
To start receiving the payment providers will need to make an undertaking to the Department that they will provide good quality and quantity of goods and services to meet the living needs of resident and meet the quarterly reporting obligations.
The undertaking must be made by 21 July 2021, and payment will cease if the reporting obligations are not met.
Minister Hunt said the 30 per cent increase in the homeless and viability supplements paid to the residential sector would also continue to ensure providers are well placed to keep offering services, especially to vulnerable senior Australians.
Minister Colbeck said the allocation of 80,000 new home care packages would ensure senior Australians could live at home for longer,
“Over the coming two years, 80,000 new home care packages will be steadily released, which will build on the 83,105 packages released since the 2018‑19 Budget,” Minister Colbeck said.
“This equates to more than 750 packages each week.
“Our Government is supporting more senior Australians who choose to remain in their homes for longer as they age.”
According to latest data there are 167,124 senior Australians receiving services through a package as at 31 March 2021.
Home care packages have increased from 59,300 under Labor in 2011-12 to 275,597 forecast for 2024-25, an increase of 365 per cent.
Over the same period, funding will increase by 576 per cent due to growth in high-level home care packages.
Additionally, from today, measures will be implemented to reduce the use of restrictive practices.
The Aged Care and Other Legislative Amendment (Royal Commission Response No.1) Bill 2021 will:

  • Strengthen regulation for the use of restrictive practices, such as chemical and physical restraint, as a last resort;
  • Establish assurance review arrangements for home care delivery and administration; and
  • Abolish the requirement for the Aged Care Financing Authority (ACFA) to make way for new governance arrangements.

Minister Colbeck said the new provisions in the legislation clarify and strengthen provider responsibilities.
Use of alternative behaviour management strategies will now ensure safer care for those most vulnerable receiving care, particularly those living with dementia.
“Increased regulation, training and oversight on the use of restraints will help carers, the aged care workforce, and the sector comply with the strengthened legislation, facilitating safer and higher quality care for senior Australians,” he said.
Assurance reviews will also apply to up to 500 home care providers each year, from November 2021.
“The reviews will examine fees and charges applied by home care providers, to ensure senior Australians are not facing unjustified costs,” Minister Colbeck said.
Other important reforms starting today include:

  • $178.9 million for Primary Health Networks (PHN) to support senior Australians’ health, including improved access to telehealth care and enhanced out of hours support for aged care residents, new health pathways to support assessment and referral, and early monitoring and identification of health needs to support people to live at home for longer;
  • Additional funding of $125.7 million over four years to support the National Aboriginal and Torres Strait Islander Flexible Care services and Multi-Purpose Services;
  •  $45.4 million for medication management in residential aged care, including the use of electronic national residential medication charts;
  • $42.8 million to boost the Aged Care Access Incentive to increase face-to-face servicing by general practitioners in residential aged care;
  • $37.3 million to expand the Greater Choice for At Home Palliative Care initiative to all 31 PHNs;
  • Support for expanded independent advocacy to deliver greater choice for senior Australians, improved quality safeguards, and diversity assistance for providers;
  • Enhanced reporting for residential aged care providers to meet financial and prudential monitoring requirements to improve compliance and intervention;
  • The assumption of responsibility of the Australian Commission on Safety and Quality in Health Care for setting clinical care components of the aged care quality standards; and
  • Work to establish a local network of Department of Health aged care staff to focus on stewardship and coordination of aged care services, starting with eight PHN regions.

The Aged Care Sector Committee will also finish and be replaced with the new National Aged Care Advisory Council.
A dedicated Council of Elders for senior Australians will be established to provide advice to Government, informed by experience, to ensure those who are most central to the system can help direct and shape the way it operates.
Membership arrangements for the new National Aged Care Advisory Council and Council of Elders are currently being considered.

LNP say they are Guaranteeing Medicare

The Morrison Government is investing record funding in Medicare, providing more support to Australians as we face some of the greatest health challenges in a generation. Our commitment to Medicare is rock solid.
We are investing $125.7 billion in Medicare over the forward estimates, an increase of over $6 billion since last year’s Budget. This is up 58% from when Labor were last in government.
This includes $204.6 million to extend the Medicare Benefits Schedule (MBS) telehealth arrangements until 31 December 2021, bringing the total investment in telehealth to $3.6 billion. This is continuing to provide access to health services for all Australians regardless of where they live. Importantly patients whose movements are restricted by a State or Territory public health order can continue to access support through telehealth.
Through the 2021-22 Budget, the Government invested a further $711.7 million to add new services and strengthen existing services on the MBS. For example, $40.5 million has been committed for ambulatory blood pressure monitoring – a new service for diagnosing high blood pressure (hypertension) that provides greater accuracy for diagnosis through continuous monitoring over 24 hours. Ambulatory blood pressure monitoring is superior to the currently MBS funded service of discrete blood pressure measurements in a clinic, or using home blood pressure monitors in conjunction with GP consultations.
From 1 July 2021, changes to the MBS items for orthopaedic, cardiac and general surgery services will be implemented following recommendations of the independent, clinician-led MBS Taskforce Review.
The changes are part of the most comprehensive review of Medicare since it began, with the aim of modernising the system to ensure it supports high quality health and medical practice.
They result from a five year process by the MBS Review Taskforce, including detailed consideration by committees led by medical experts, and extensive consultation with relevant medical organisations and the public.
As well as revised Medicare rebates, the changes include the addition of new items, the revision of some items and removal of other obsolete items, to reflect contemporary best practice.
They will improve the quality and safety of care for patients, support high value care, and simplify the MBS.
The majority of the changes coming into effect on 1 July 2021 relate to orthopaedic surgery items, which make up about 10 per cent of all MBS items.
Medicare rebates have been reviewed to reflect the cost and complexity of performing each service. They will assist consumers in accessing the best available medical treatment and ensure a more consistent approach to billing by providers.
Rebates will significantly increase for a number of items. Rebates will rise for nine existing items for general surgery and 29 orthopaedic surgery items. For example, the Medicare rebate for revision of knee replacement (item 49533) will increase by $315 to $2,645.55.
For cardiac surgery, rebates will rise significantly across three services related to coronary bypass grafting surgery, which have been increased by 50 per cent.
Changes to general surgery consolidate the existing 138 items into 85 items and provide more flexibility for surgeons to better tailor treatment to patients.
Private Healthcare Australia has publicly supported the 1 July 2021 changes, noting most patients would not pay increased out-of-pocket costs and that rebates have increased for a range of orthopaedic procedures.
The Government will closely monitor the impact of the 1 July 2021 changes to ensure there are no unintended consequences to patients. We are also committed to working in partnership with the sector, including the AMA, private health insurers and private hospitals, to implement future changes to the MBS recommended by the MBS Review Taskforce.
Further information about the 1 July 2021 changes to the MBS is available at: www.health.gov.au/mbsonline

Key measures take effect to lower taxes and create jobs

The Morrison Government is continuing to secure Australia’s recovery from COVID-19 with key measures taking effect on 1 July 2021 to create more jobs, rebuild our economy and set Australia up for the future.
These measures will provide tax relief to millions of hard-working Australians, incentivise businesses to invest and ensure our superannuation system works harder for you.
Retaining the low-and middle-income tax offset
The Government is delivering further personal income tax cuts to support more than 10 million low‑and middle‑income earners. These tax cuts are worth up to $1,080 for individuals or up to $2,160 for couples. This is more money to spend in local businesses, giving them the confidence to take on an extra worker, offer an extra shift or buy a new piece of equipment.
Providing tax incentives for businesses
The Government is further supporting businesses by extending its temporary full expensing and temporary loss carry-back measures beyond this financial year.
This will allow more than 99 per cent of businesses employing 11.5 million Australians to deduct the full cost of eligible depreciable assets of any value in the year they are installed until 30 June 2023.
These measures are estimated to boost GDP by around $7.5 billion in 2021‑22 alone and create around 60,000 jobs by the end of 2022-23.
Cutting taxes for small and medium businesses
The tax rate for small and medium companies with turnover below $50 million will decrease from 26 per cent to 25 per cent. For unincorporated small business such as sole traders, the tax discount rate will increase from 13 per cent to 16 per cent (up to the existing cap of $1,000). Access to a range of small business tax concessions will also be expanded with the turnover threshold rising from $10 million to $50 million, providing tax relief and reducing red tape for eligible businesses.
Supporting business research and development
Reforms to the Research and Development Tax Incentive take effect from 1 July. This includes generous tax offset rates above the company tax rate and includes an intensity test to reward companies that commit a greater proportion of their expenditure to R&D. In addition, the cap on eligible R&D expenditure will rise from $100 million to $150 million per annum.
Providing tax relief for small brewers and distillers
As announced in the 2021‑22 Budget, the Excise remission scheme for alcohol manufacturers will provide brewers and distillers a full remission of any excise they pay, up to an annual cap of $350,000.
This builds on the Government’s 2020‑21 MYEFO announcement to allow eligible alcohol manufacturers to receive their excise duty remission automatically, which reduces administrative overheads and provides additional assistance by addressing cash flow concerns. These changes also commence from 1 July.
Exempting granny flat arrangements from capital gains tax (CGT)
The Government is supporting older and disabled Australians and their families by providing a targeted CGT exemption for granny flat arrangements. From 1 July, CGT will not apply to the creation, variation or termination of formal written granny flat arrangements providing accommodation for older Australians or people with disabilities.
This change removes the CGT impediments to families entering into legally enforceable granny flat arrangements, reducing the risk of financial abuse to vulnerable Australians.
Supporting first home buyers and single parent families
From 1 July, the Government will release an additional 30,000 places to eligible applicants under the First Home Loan Deposit Scheme, the New Home Guarantee program, and the Family Home Guarantee.
As announced in the 2021-22 Budget, the Government will establish the Family Home Guarantee to support single parents with dependants. From 1 July, 10,000 guarantees will be made available to eligible single parent families to build a new home or purchase an existing home with a deposit of as little as 2 per cent.
The Government will also extend the New Home Guarantee for a second year, providing an additional 10,000 places in 2021-22 for first homebuyers seeking to build a new home or purchase a newly built home with a deposit of 5 per cent.
Making superannuation work harder for Australians
As part of the most significant changes to superannuation in nearly 30 years, the Government is holding underperforming funds to account and strengthening protections for the retirement savings of millions of Australians.
The Government will require superannuation products to meet an annual objective performance test. Funds with products that fail the test will be required to inform members, while persistently underperforming products will be prevented from taking on new members. Members will be notified by 1 October 2021 if their product fails this test.
Australians will also have access to a single, trusted and independent source of information to compare superannuation products through a new interactive online YourSuper comparison tool from 1 July. In addition, trustees will be required to demonstrate how their actions are in the best financial interest of members.
The Your Future, Your Super reforms are estimated to save Australian workers $17.9 billion over 10 years.
Increasing flexibility for self-managed superannuation funds
The Government is providing Australians with more flexibility and control in managing their retirement savings. From 1 July, the maximum number of allowable members in self-managed superannuation funds and small APRA funds will increase from four to six.
Extending the temporary reduction in superannuation minimum drawdown rates
As part of the Government’s COVID-19 response, the superannuation minimum drawdown rates were reduced by 50 per cent for the 2019‑20 and 2020‑21 income years. To further support retirees and provide extra flexibility, the Government has recently extended the temporary reduction to the 2021-22 income year.
Implementing Financial Services Royal Commission recommendations
Consumers will continue benefitting from the Government’s strong record on implementing recommendations of the Hayne Royal Commission, with several reforms taking effect from 1 July.
A new independent body, the Financial Regulator Assessment Authority, will be established to review and report on the effectiveness and capability of the Australian Securities and Investments Commission and the Australian Prudential Regulation Authority.
To address the Royal Commission’s concerns about fees for no service, the enhanced framework around providing financial advice to clients under ongoing fee arrangements starts. To assist with this transition, the Government has recently made a regulation to lower compliance costs for generating fee disclosure statements. There is also a new disclosure obligation to ensure financial advisers who are not ‘independent’ provide clients with a clear and concise written disclaimer.
In the area of superannuation, there are new measures to prohibit the deduction of ongoing advice fees from MySuper products and to increase the transparency of fees to members. To address concerns about conflict, there is a new measure prohibiting superannuation trustees from having a duty to act in the interests of another except those arising from its role as trustee. The Royal Commission recommendation that individuals be ‘stapled’ to a single super account has passed the parliament and will commence on 1 November 2021.
Cutting Cross-Border Red Tape for Tradies and Skilled Workers
Automatic mutual recognition (AMR) of occupational licences comes into effect across New South Wales, Victoria, the Australian Capital Territory and the Northern Territory. This will enable licensed workers including plumbers, builders and architects to operate across jurisdictions, without having to apply, pay for and wait for a further licence to perform the same type of work in another state or territory. These measures, which will be implemented progressively, will provide a $2.4 billion boost to the economy and directly benefit over 168,000 workers each year. Other states are expected to join the scheme subject to the passage of legislation.
Extending the Junior Minerals Exploration Incentive (JMEI)
The Government is extending the JMEI by four years to incentivise new investment in small minerals exploration companies undertaking greenfields minerals exploration in Australia.
Balancing the rights of franchisors and franchisees
Significant changes to the Franchising Code of Conduct start today. This includes reforms to better balance the rights of franchisors and franchisees and improve access to justice though additional, more efficient dispute resolution processes.
Improving payment times for suppliers in government contract supply chains
From 1 July 2021, large businesses awarded government contracts valued above $4 million will be required to pay their suppliers with subcontracts of up to $1 million within 20 calendar days, or pay interest.
Rolling out the Consumer Data Right
Starting from 1 July 2021 — exactly 12 months after the big four banks — the rollout of Open Banking by the remaining banks is set to occur. This means that even more Australians will now be able to securely access and share their banking data to access better value products and services.
Introducing licencing obligations for debt management services
From 1 July, providers of debt management services will be required to hold an Australian credit licence and meet ongoing obligations imposed on licensees. These regulations form part of the Government’s consumer credit reforms.
Together, these comprehensive measures help secure Australia’s recovery from COVID-19 by putting more money in the pockets of hard-working Australians and supporting job creation.

Recycling industry ignored in lead-up to waste export ban

The Government’s failure to mandate Australia’s recycling targets is to blame for any recyclable items sent to landfill because of tomorrow’s introduction of a waste export ban.
Greens spokesperson for Waste and Recycling, Senator Peter Whish-Wilson, said the waste and recycling sector’s concerns about tomorrow’s change were not new.
“The recycling industry has been very clear in voicing its concerns and demands in the lead-up to the national waste export ban, and the Environment Minister chose to ignore these.
“The recycling sector has consistently called for mandatory national packaging targets – such as minimum recycled content in packaging – in order to have the confidence to invest in the infrastructure necessary to process plastic and other wastes banned from export.
“The Recycling and Waste Reduction Bill 2020 would have mandated the Australian Packaging Covenant Organisation’s voluntary recycling and packaging targets, had the Liberal Party not refused to support Greens amendments.
“These targets were supported by the recycling industry and a broad range of stakeholders, but the Liberals let party politics get in the way of introducing good legislation.
“The recycling industry has made it abundantly clear that voluntary packaging and recycling targets have been a complete failure in the past. The industry clearly has no trust that voluntary targets will be met by packaging companies in the future without government intervention.
“Confidence in meeting these targets is critical to the recycling sector as it provides the certainty necessary to underpin investments and upgrades in recycling technology and capacity in this nation, all of which is necessary to effectively deal with our own waste problems.
“The Liberal National Party coalition has repeatedly chosen to back big packaging companies that oppose mandatory targets over a recycling industry that demands them, and which employs over 60,000 Australians.
“The reason the recycling industry continues to be sidelined by the Liberal National Party coalition is because this Government is more concerned with receiving donations from powerful packaging companies than supporting local communities and the environment.”

$180 million in medical research to improve the lives of Australians

The Morrison Government is investing $180 million in ground-breaking medical research projects around Australia to improve the lives of Australians and their loved ones.
Funded through the Government’s $20 billion Medical Research Future Fund, 106 medical research projects will receive funding to improve health outcomes, including for Australians with cancer, dementia, brain injuries, heart problems, neurofibromatosis and many others.
$18.7 million will be provided through the Stem Cell Mission for 17 projects that will address illnesses facing many Australians and their families, including heart disease, COVID-19, epilepsy and childhood cancer.
The Murdoch Children’s Institute will receive almost $1 million to evaluate the potential of a bioengineered heart tissue to be used for congenital heart repair in children. This project will radically transform patient outcomes and improve the quality of life of children affected by heart disease.
Through the Genomics Health Futures Mission, 17 researchers will receive a share of $46.5 million for genomics research, which will support health clinicians to identify genetic disorders and diagnose rare diseases faster, positioning Australia as a global leader in this area.
Australian researchers fighting against paediatric and childhood cancers will also receive $18.4 million as part of the 2020 Paediatric Cancer Grant Opportunity and 2020 Childhood Cancer Research Grant Opportunity, to improve treatment, therapies and survival rates for Australian kids.
To improve health outcomes for Australian patients, we’re investing $12.9 million in seven research projects that will use data to improve access, quality, safety and efficiency of our primary health care system as part of the 2020 Primary Healthcare Research Data Infrastructure grants.
Monash University will receive $9.6 million to focus on discovery research projects, including next-generation precision oncology, tumour immunotherapy and epigenomics, which will help make a real world difference for the thousands of Australian kids each year facing a cancer diagnosis and the fight of their lives.
Cancer remains the leading cause of death in Australia. We’re providing $21 million through the 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity to eight projects, which aim to improve the early diagnosis of ovarian cancer, liver cancer, lung cancer, as well as cancers where the primary site or origin is unknown.
We are supporting home grown research into cardiovascular health, with $20.1 million in new funding to support 16 projects from real-time cardiac monitoring, to after stroke care for Aboriginal and Torres Strait Islander patients, from medicine management for stroke patients to arm strength and rehabilitation.
We’re providing $17 million for 11 research projects as part of the Dementia, Ageing and Aged Care Mission, which will help senior Australians maintain their health and quality of life as they age, keep their independence for longer and access quality care when they need it.
Seven projects will receive a share of $7.4 million to improve the health of Aboriginal and Torres Strait Islander people through the 2020 Indigenous Health Research Grant Opportunity.
Australian researchers at the University of Melbourne are investigating further COVID-19 vaccine candidates. Through the COVID-19 Vaccine Candidate Research grants, we’re providing $6 million to the University for two projects to help protect Australians against future pandemics.
The 2020 International Clinical Trial Collaborations grant opportunity is providing $5.6 million for three projects, which will bring international clinical trials into back pain, caesarean births and Hodgkin lymphoma.to Australia.
$4.6 million will also be provided through the 2020 Neurofibromatosis Research grant opportunity to four Australian research projects looking into neurofibromatosis – a devastating genetic condition that can cause cancer, blindness, deafness, and chronic pain.
To help improve the lives of Australians who have suffered a traumatic brain injury (TBI), we’re providing $3.3 million to six projects through the Traumatic Brain Injury Mission.
These grants are part of the Morrison Government’s $20 billion Medical Research Future, which is a long-term, sustainable investment in Australian health and medical research helping to improve lives, build the economy and contribute to the sustainability of the health system.
Further information about the MRFF is available at www.health.gov.au/mrff

2020 Genomics Health Futures Mission Grant Opportunity

Institution Project Funding
Murdoch Children’s Research Institute The Australian Functional Genomics Network $6 million
Murdoch Children’s Research Institute A national large-scale automated reanalysis program to increase rare disease diagnosis $3 million
Murdoch Children’s Research Institute New technologies for improved diagnosis of ataxia and the repeat expansion disorders $653,000
Murdoch Children’s Research Institute Mitochondrial Diagnostic Network for Genomics and Omics $3 million
Murdoch Children’s Research Institute The Australian Undiagnosed Diseases Network (UDN-Aus): An internationally networked national approach for transforming diagnosis for individuals living with rare diseases $3 million
James Cook University The KidGen National Kidney Genomics Program – improving genomic outcomes for Australian families with genetic kidney disease $3 million
University of Western Australia Closing the gap in diagnosis of neurological disorders including ataxias and neuropathies – a trans-Australia collaboration $3 million
University of Melbourne Genetic mosaicism as a stable and robust blood DNA biomarker for precision risk assessment for cancer $2.1 million
University of Melbourne Precision Diagnosis for the Remaining 50% of Unsolved Developmental and Epileptic Encephalopathies $3 million
University of Melbourne Diagnosis, discovery and novel phenotype characterisation using multimodal genomics in patients with inherited bone marrow failure and related disorders $3 million
University of Melbourne Evaluating clinically relevant biomarkers to improve early detection and treatment of head and neck cancer $2.2 million
University of Melbourne Novel predictive disease modelling using liquid biopsies to improve outcomes in melanoma $2 million
University of Sydney Genomic risk prediction and risk-tailored screening and early detection for common cancers $3 million
Monash University Population genomic screening of young adults to prevent cancer in Australia $3 million
University of Queensland Improving genomic testing rates for inoperable lung cancer patients $2.5 million
Flinders University A liquid biopsy DNA methylation blood test for personalised treatment of patients with gastrointestinal cancers $2 million
Macquarie University Integrated Multimodal Precision Liquid biopsy to Enhance MElanoma and NSCLC Treatment (IMPLEMENT) $2 million

2020 Stem Cell Therapies Mission Grant Opportunity

Institution Project Funding
Murdoch Children’s Research Institute Evaluating safety and efficacy of bioengineered heart tissue for congenital heart repair $999,000
Murdoch Children’s Research Institute New therapies preventing heart damage during chemotherapy $879,000
Murdoch Children’s Research Institute Stem cell models of glomerular kidney disease for understanding disease and developing treatments $934,000
Murdoch Children’s Research Institute  
Insights into CDKL5 neuronal regulation: pathways to improving neurological outcomes for CDKL5 Deficiency Disorder
$854,000
University of Melbourne Stem cell therapies for digestive disease $584,000
University of Melbourne iPSC clinical trials – population wide screening of patient iPSC’s to reassess high value drug targets for motor neuron disease $1 million
University of Sydney Induced pluripotent stem cell derived cardiomyocytes: a new therapy for “no-option” end stage heart failure
 
$5 million
University of Sydney Stem Cell Derived-Retinal Organoids to Test Novel Genetic Therapies $498,000
University of Sydney  
Improving decisions about access to stem cell interventions
 
$800,000
Monash University Locally administered extracellular vesicles for perianal fistulising Crohn’s disease $936,000
The University of Adelaide A Precision Medicine Based Approach to Treat Craniosynostosis in Children $441,000
The University of Adelaide Developing an Evidence-Based Model for Building Trust in Australian Stem Cell Research and Therapies $995,000
University of Wollongong Novel SMART AAV vectors for gene therapy for Friedreich’s Ataxia $983,000
The University of Queensland Transforming the paradigm of epilepsy care with precision medicine $1 million
University of South Australia Identification and assessment of new treatment options for the childhood cancer Neuroblastoma $982,000
South Australian Health and Medical Research Institute Limited Engineered human stem cells for mutation-specific eradication of myelofibrosis $853,000
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) the sySTEMs initiative: systems biology-augmented, stem cell-derived, multi-tissue panel for rapid screening of approved drugs as potential COVID-19 treatments $998,000

2020 Paediatric Cancer Grant Opportunity

Institution Project Funding
Monash University The Victoria Paediatric Cancer Consortium: A multi-institutional partnership to catalyze advances in childhood cancer research and clinical implementation $9.6 million

2020 Childhood Cancer Research Grant Opportunity

Institution Project Funding
University of New South Wales Improving outcomes for children with high risk cancer $1.5 million
University of New South Wales Rationalised inclusion of HDAC inhibitors with standard-of-care chemotherapy to improve outcomes for primary and relapsed neuroblastoma $614,000
University of Melbourne Studying the origins, maintenance and resistance mechanisms of poor prognosis paediatric leukaemia at single cell resolution to develop novel therapeutic approaches. $1.5 million
University of Sydney Alternative Lengthening of Telomeres (ALT): Target discovery to treatment $1.48 million
The University of Adelaide Adolescents with Acute Lymphoblastic Leukaemia: Focussing on the gut microbiota, its role in therapeutic response and potential as an effective adjunct therapeutic in this high-risk group $1.29 million
University of South Australia ABOLISH Neuroblastoma: Defining the Aetiology and underlying BiOLogy of neuroblastoma to Innovate and SHape new options for prevention, diagnosis and treatment $1.42 million
St Vincent’s Institute of Medical Research Reducing tumour incidence in adolescents with germ-line mutations in RECQL4 $958,000

2020 Primary Healthcare Research Data Infrastructure Grant Opportunity

Institution Project Funding
The University of Queensland Improving surveillance infrastructure for Indigenous primary health care  $2 million
South Australian Health and Medical Research Institute Limited Registry of Senior Australians: Improving Care and Outcomes in Aged Care $2 million
University of Melbourne Platform to Enhance Prostate Cancer Shared care Integration (PEPSI)
 
$2 million
Monash University
 
Optimising health information exchange during aged care transfers   $2 million
The University of Adelaide Imagendo: Diagnosing endometriosis with imaging and AI $2 million
Kimberley Aboriginal Medical Services Limited Regional collaboration to create a Kimberley Health Evidence Data Platform.  $1 million
Menzies School of Health Research Territory Integrated Care: Primary health data Linkage Using Software $2 million

2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity

Institution Project Funding
University of New South Wales
 
Microbial based biomarkers powered by artificial intelligence for early detection of liver cancer in Australia. The Australian Liver Cancer Microbiome Consortium $4 million
University of South Australia
 
Predicting and Preventing Ovarian Cancer: a machine learning approach $1.3 million
The University of Queensland
 
Implementing a Multivariate Index Assay for the Earlier Detection of Ovarian Cancer $2.7 million
The University of Queensland
 
Lung cancer screening for early detection $2.8 million
University of Sydney
 
Ready to screen. Targeting the high-risk population to improve lung cancer diagnosis $2 million
University of Western Australia
 
The IC3 Trial: Identifying Cirrhosis and Liver Cancer in Primary Care $3.2 million
Swinburne University of Technology
 
Solving Unknown Primary cancER Earlier Diagnosis (SUPER-ED): A stepped wedge cluster randomised controlled trial implementing a new model of care to support earlier diagnosis $2.4 million
Flinders University
 
Shining Light into the “unknown” on Indigenous and non-Indigenous Australians with Cancer of Unknown Primary $2.4 million

2020 Cardiovascular Health Grant Opportunity

Institution Project Funding
Monash University Statins and Progression of Coronary Atherosclerosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors $1.7 million
Monash University ECMO-Rehab: A Randomised Controlled Trial of Early Cardiac Rehabilitation to Improve Survival and Recovery in Critically-ill Patients on ECMO $663,000
Monash University New models of rehabilitation to improve work and health outcomes after stroke $1 million
The University of Newcastle Stroke in patients with large Ischaemic Core: Assessment of Reperfusion therapy Impact on Outcome (SICARIO) $1.5 million
The University of Newcastle Yarning up After Stroke $485,000
University of Sydney Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS) $2.7 million
University of Sydney LesioLogic $1.1 million
University of Sydney Digital solutions for heart failure best practice care $937,000
University of Sydney Guardian Angel: Implementation of a peer support program for people with heart disease $656,000
University of Melbourne REACHING FOR YOUR WORDS: A Phase IIa umbrella trial of integrated UPper limb & Language Impairment and Functional Training (UPLIFT) after stroke. $993,000
University of Melbourne Improving life after stroke with tailored support: Innovation in use of national registry data $506,000
The University of Adelaide The SPRINTS Project: Stroke – Prevention of Reperfusion Injury and Neuroinflammation – a Therapeutic Strategy $2.6 million
University of New South Wales Development of novel, clinically viable strategies for reducing cardiac damage and preventing future events in myocardial infarction (MI) survivors by targeting inflammation $2.8 million
University of New South Wales CardiacAI: Deep learning to predict and prevent secondary cardiovascular events $545,000
The University of Queensland Measuring, Monitoring, and Motivating Adherence to Self-Managed Aphasia Treatment $389,000
The University of Queensland Development of drugs to prevent ischemic injuries of the heart and brain $1,499,560

2020 Dementia, Ageing and Aged Care Grant Opportunity

Institution Project Funding
The University of Queensland Alignment, Harmonisation, and Results: translating Core Outcome Measures to Improve Care (COM-IC) for People Living with Dementia into Australian practice $999,000
The University of Queensland Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT) $1.6 million
National Ageing Research Institute Drawing out care: Using animation and digital technologies to support Culturally and Linguistically Diverse (CALD) family carers and people living with dementia $798,000
Monash University Knowledge brokers for evidence translation to improve quality use of medicines in residential aged care $2 million
Macquarie University
 
SENSEcog aged care: Hearing and vision support to improve quality of life for people living with dementia in residential aged care $1.2 million
Flinders University Creating partnership in iSupport program to optimise carers’ impact on dementia care $1.4 million
University of New South Wales Development, validation and implementation of a computerised tool to assess instrumental activities of daily living $1.3 million
Florey Institute of Neuroscience and Mental Health Blood testing to predict and discriminate dementias $4 million
University of Melbourne Music Attuned Technology Care eHealth (MATCH): A music based mobile eHealth $2 million
University of Melbourne Development and Implementation of the National Infection Surveillance Program for Aged Care (NISPAC) $998,000
University of Melbourne IMpleMenting Effective infection prevention and control in ReSidential aged carE (IMMERSE) $758,000

Indigenous Health Research Fund – 2020 Indigenous Health Research

Institution Project Funding
The University of Adelaide Working with Aboriginal families and health and social service providers to assess the feasibility of a novel care package to reduce cannabis and alcohol use and social stress in pregnancy $675,000
The Council of the Queensland Institute of Medical Research Developing cultural sensitivity and capability through communication training for mental health professionals $705,000
University of New South Wales Understanding how cultural resilience impacts Aboriginal health & quality of life $560,000
University of Sydney Understanding the contribution of Aboriginal and Torres Strait Islander culture and wellbeing to health: Implementation of the What Matters 2 Adults wellbeing measure
 
$998,000
La Trobe University Healing the Past by Nurturing the Future: Trauma-integrated perinatal care to improve health outcomes for Indigenous parents and infants in a rural setting $1.5 million
University of Sydney VOICE – Validating Outcomes by Including Consumer Experience. Developing a patient reported experience measure for Aboriginal and Torres Strait Islander people accessing primary health care $1.4 million
The Sax University Indigenous Led Evaluation of Aboriginal Programs (ILEAP) $1.5 million
 

2020 COVID-19 Vaccine Candidate Research Grant Opportunity – Round 3

Institution Project Funding
University of Melbourne AdaptiVax-CoV: A novel adaptable SARS-CoV2 VLP vaccine to produce broad humoral and T cell responses to S, E and M viral proteins $3 million
University of Melbourne Chimeric next generation COVID vaccines $3 million

2020 International Clinical Trial Collaborations

Institution Project Funding
Macquarie University Determining the impact of a new primary care model for low back pain: A cluster randomised trial $2.1 million
University of Melbourne The C*STEROID Trial: An international, randomised placebo-controlled trial to determine the effect of antenatal corticosteroids on newborn health when given prior to planned caesarean section birth from 35+0 to 39+6 weeks of pregnancy $2.2 million
University of Sydney RADAR: A randomised PET-adapted study of bleomycin-free treatment of early stage Hodgkin lymphoma $1.4 million

2020 Neurofibromatosis Research grant opportunity

Institution Project Funding
Murdoch Children’s Research Institute Malignant Peripheral Nerve Sheath Tumour Genomics in Neurofibromatosis 1 (MaGeN) $1.6 million
The University of Newcastle The Neurofibromatosis type 1 (NF1) Cutaneous Neurofibroma Consortium: Identifying Genetic modifiers of disease burden to inform treatment pathways $1.6 million
Monash University Defining NF1 clinical variation at the microscale to discover new therapeutic targets $818,000
Murdoch Children’s Research Institute A randomised control trial of remote microphone listening devices in children with neurofibromatosis type 1 and central auditory deficits $599,000

2020 Traumatic Brain Injury Mission

Institution Project Funding
Curtin University An informatics approach to predict outcomes and monitor intervention efficacy following moderate to severe traumatic brain injury $500,000
University of Sydney From injury to long-term physical activity for people living with traumatic brain injury $407,000
Monash University PRECISION-TBI – Promoting evidence-based, data driven care for critically ill moderate-to-severe TBI patients $499,000
Monash University The Australian Traumatic Brain Injury National Data (ATBIND) Project $366,000
Monash University Exercise therapy for mild traumatic brain injury (mTBI) and persistent post-concussion symptoms (PPCS) across the lifespan $500,000
University of Tasmania Transforming Awareness, Literacy & Knowledge of Traumatic Brain Injury (TALK-TBI) $1 million

Suspension of mutual obligation requirements for job seekers and participants in Queensland

The Morrison Government has suspended mutual obligation requirements for employment services participants in Queensland in the Local Government Areas of Townsville, Palm Island, Brisbane, Gold Coast, Ipswich, Lockyer Valley, Logan, Moreton Bay, Noosa, Redland, Scenic Rim, Somerset and Sunshine Coast.
The temporary suspension of mutual obligation requirements for employment services participants in these areas will be in place from today, Tuesday 29 June until Tuesday 6 July 2021 inclusive.
No employment services participant in the affected Local Government Areas will face payment suspension or financial penalties for failing to meet their mutual obligation requirements, such as not being able to attend appointments or activities, or not meeting their Job Search requirement if it is due while mutual obligation requirements are suspended.
Where it is safe to do so in line with health advice, employment services participants can engage with their employment services provider.
These arrangements will apply to job seekers in jobactive, Online Employment Services, Disability Employment Services, and participants in ParentsNext and the Community Development Program.
More information about mutual obligation requirements for jobactive, Online Employment Services, and participants of ParentsNext can be found at www.dese.gov.au/covid-19/job-seekers